MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/eci.13381

Медицинская библиотека · European journal of clinical investigation · 2020

Secondary mitral regurgitation-Insights from microRNA assessment.

Spinka Georg, Bartko Philipp E, Pavo Noemi, Freitag Claudia, Zlabinger Katrin, Prausmüller Suriya, Arfsten Henrike, Heitzinger Gregor, Mascherbauer Julia, Hengstenberg Christian, Gyöngyösi Mariann, Hülsmann Martin, Goliasch Georg

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

While secondary mitral regurgitation (sMR) is associated with adverse outcome in heart failure with reduced ejection fraction (HFrEF), key pathophysiologic mechanisms remain poorly understood and might be elucidated by microRNAs (miRNA/miR), that were recently related to cardiac remodelling. This study sought to assess (i) the differences of miRNA profiles in patients with severe sMR compared to matched disease controls, (ii) the correlation between circulating miRNAs and surrogates of sMR severity as well as (iii) the prognostic implications of miRNA levels in severe sMR.

MATERIALS AND

METHODS

Sixty-six HFrEF patients were included, of these 44 patients with severe sMR 2:1 matched to HFrEF controls with no/mild sMR. A comprehensive set of miRNAs (miR-21, miR-29a, miR-122, miR-132, miR-133a, miR-let7i) were measured and correlated to echocardiographic sMR severity.

RESULTS

miRNA patterns differed distinctly between patients with severe sMR and HFrEF controls (P < .05). Among the panel of assessed miRNAs, miR-133a correlated most strongly with surrogates of sMR severity (r = -0.41, P = .001 with sMR vena contracta width). Interestingly, elevated levels of miR-133 were associated with an increased risk for cardiovascular death and/or HF hospitalizations with and adjusted HR of 1.85 (95% CI 1.24-2.76, P = .003).

CONCLUSIONS

This study unveils distinct pathophysiologic maladaptions at a cellular level in patients with severe sMR compared to no/mild sMR by showing significant differences in miRNA profiles and correlations with sMR severity, supporting the concept that sMR drives cardiac remodelling in heart failure. Moreover, the increased risk for adverse outcome in HFrEF patients with severe sMR conveyed by miR-133a might indicate irreversible myocardial damage.

Для цитирования: Spinka Georg, Bartko Philipp E, Pavo Noemi, Freitag Claudia, Zlabinger Katrin, Prausmüller Suriya, Arfsten Henrike, Heitzinger Gregor, Mascherbauer Julia, Hengstenberg Christian, Gyöngyösi Mariann, Hülsmann Martin, Goliasch Georg. Secondary mitral regurgitation-Insights from microRNA assessment.. European journal of clinical investigation. 2020. DOI: 10.1111/eci.13381.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.